Esperion Therapeutics, Inc. (ESPR)

NASDAQ: ESPR · Real-Time Price · USD

3.130

0.00 (0.00%)

At close: May 29, 2026, 4:00 PM EDT

3.120

-0.010 (-0.32%)

After-hours: May 29, 2026, 6:54 PM EDT

Esperion Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	156.16	167.85	144.76	82.25	124.78	208.89
Short-Term Investments	-	-	-	-	42.09	50.44
Cash & Short-Term Investments	156.16	167.85	144.76	82.25	166.86	259.33
Cash Growth	36.22%	15.95%	76.00%	-50.71%	-35.66%	-14.96%
Accounts Receivable	132.35	140.19	80.14	48.49	33.73	22.93
Inventory	104.21	105.12	94.49	65.62	35.2	34.39
Other Current Assets	66.74	49.4	18.6	4.7	10.89	12.31
Total Current Assets	459.46	462.57	338	201.07	246.68	328.97
Net Property, Plant & Equipment	3.01	3.26	5.77	4.68	1.2	2.56
Other Intangible Assets	0.06	0.06	0.06	0.06	0.06	0.06
Other Long-Term Assets	-	-	-	-	-	50
Total Assets	462.53	465.89	343.82	205.8	247.94	381.59
Accounts Payable	68.41	65.07	51.65	31.72	23.04	17.56
Accrued Expenses	105.98	111.57	81.16	62.72	40.62	37.42
Short-Term Debt	-	-	54.58	-	-	-
Current Portion of Leases	1.7	2.1	2.74	1.55	0.38	1.39
Unearned Revenue	43.53	34.48	8.52	25.4	3.51	5.68
Other Current Liabilities	80.75	87.6	47.59	34.83	24.76	11.3
Total Current Liabilities	300.36	300.81	246.23	156.22	92.31	73.35
Long-Term Debt	250.07	249.48	237.72	261.6	259.9	258.28
Long-Term Leases	0.86	0.65	2.57	3.02	0.67	0.52
Other Long-Term Liabilities	219.17	216.91	246.02	239.95	218.85	246.38
Total Long-Term Liabilities	470.1	467.04	486.31	504.57	479.41	505.18
Total Liabilities	770.46	767.85	732.54	660.79	571.72	578.53
Common Stock	0.26	0.25	0.2	0.12	0.08	0.06
Treasury Stock	-55	-55	-55	-55	-55	-55
Additional Paid-in Capital	1,396	1,377	1,267	1,149	1,071	964.4
Accumulated Other Comprehensive Income	-	-	-	-	-0	-0.03
Retained Earnings	-1,649	-1,624	-1,601	-1,549	-1,340	-1,106
Shareholders' Equity	-307.93	-301.97	-388.72	-454.99	-323.78	-196.94
Total Liabilities & Equity	462.53	465.89	343.82	205.8	247.94	381.59
Total Debt	252.63	252.23	297.6	266.17	260.95	260.2
Net Cash (Debt)	-96.47	-84.38	-152.84	-183.92	-94.09	-0.86
Net Cash Per Share	-0.41	-0.41	-0.82	-1.78	-1.42	-0.03
Book Value	-307.93	-301.97	-388.72	-454.99	-323.78	-196.94
Book Value Per Share	-1.32	-1.45	-2.08	-4.41	-4.88	-6.81
Tangible Book Value	-307.99	-302.02	-388.78	-455.05	-323.83	-197
Tangible Book Value Per Share	-1.32	-1.45	-2.08	-4.41	-4.88	-6.82

SEC Filings: 10-K · 10-Q